In addition, in light of data suggesting that ADCs can cross the blood–brain barrier owing to disruption of the vasculature by malignant processes14,30,31, and the possible role of gpNMB in the development of brain metastases32, there may be an opportunity for GV to address the large unmet need for patients with breast cancer brain metastases. This evidence concerns the gene GPNMB and breast cancer.